182 related articles for article (PubMed ID: 26320191)
1. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
2. In vitro differentiated plasmacytoid dendritic cells as a tool to induce anti-leukemia activity of natural killer cells.
Díaz-Rodríguez Y; Cordeiro P; Belounis A; Herblot S; Duval M
Cancer Immunol Immunother; 2017 Oct; 66(10):1307-1320. PubMed ID: 28555259
[TBL] [Abstract][Full Text] [Related]
3. Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.
Belounis A; Ayoub M; Cordeiro P; Lemieux W; Teira P; Haddad E; Herblot S; Duval M
Cancer Immunol Immunother; 2020 Sep; 69(9):1767-1779. PubMed ID: 32342128
[TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.
Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
Cancer Immunol Immunother; 2013 Aug; 62(8):1359-68. PubMed ID: 23689729
[TBL] [Abstract][Full Text] [Related]
5. 2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells.
Altvater B; Landmeier S; Pscherer S; Temme J; Schweer K; Kailayangiri S; Campana D; Juergens H; Pule M; Rossig C
Clin Cancer Res; 2009 Aug; 15(15):4857-66. PubMed ID: 19638467
[TBL] [Abstract][Full Text] [Related]
6. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R
Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients.
Peragine N; Torelli GF; Mariglia P; Pauselli S; Vitale A; Guarini A; Foà R
Cancer Immunol Immunother; 2015 Feb; 64(2):201-11. PubMed ID: 25341808
[TBL] [Abstract][Full Text] [Related]
8. Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody.
Jewett A; Teruel A; Romero M; Head C; Cacalano N
Cancer Immunol Immunother; 2008 Jul; 57(7):1053-66. PubMed ID: 18188563
[TBL] [Abstract][Full Text] [Related]
9. Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligand.
Makowska A; Franzen S; Braunschweig T; Denecke B; Shen L; Baloche V; Busson P; Kontny U
Cancer Immunol Immunother; 2019 Aug; 68(8):1317-1329. PubMed ID: 31312900
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to
Messlinger H; Sebald H; Heger L; Dudziak D; Bogdan C; Schleicher U
Front Immunol; 2018; 9():24. PubMed ID: 29472914
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation.
Jewett A; Cacalano NA; Teruel A; Romero M; Rashedi M; Wang M; Nakamura H
Cancer Immunol Immunother; 2006 Sep; 55(9):1052-63. PubMed ID: 16328384
[TBL] [Abstract][Full Text] [Related]
12. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy.
Komada Y; Zhang SL; Zhou YW; Hanada M; Shibata T; Azuma E; Sakurai M
Cancer Immunol Immunother; 1992; 35(4):271-6. PubMed ID: 1511462
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
Otegbeye F; Ojo E; Moreton S; Mackowski N; Lee DA; de Lima M; Wald DN
PLoS One; 2018; 13(1):e0191358. PubMed ID: 29342200
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells.
Kaur K; Ko MW; Ohanian N; Cook J; Jewett A
Sci Rep; 2020 Nov; 10(1):20363. PubMed ID: 33230147
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.
Pegram HJ; Haynes NM; Smyth MJ; Kershaw MH; Darcy PK
Cancer Immunol Immunother; 2010 Aug; 59(8):1235-46. PubMed ID: 20376439
[TBL] [Abstract][Full Text] [Related]
16. Sex-dependent differences in type I IFN-induced natural killer cell activation.
Pujantell M; Skenteris NT; Claussen JM; Grünhagel B; Thiele RJ; Altfeld M
Front Immunol; 2023; 14():1277967. PubMed ID: 38162640
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells.
Bellucci R; Nguyen HN; Martin A; Heinrichs S; Schinzel AC; Hahn WC; Ritz J
J Clin Invest; 2012 Jul; 122(7):2369-83. PubMed ID: 22684105
[TBL] [Abstract][Full Text] [Related]
18.
Jung IH; Kim DH; Yoo DK; Baek SY; Jeong SH; Jung DE; Park SW; Chung YY
In Vivo; 2018; 32(4):771-781. PubMed ID: 29936458
[TBL] [Abstract][Full Text] [Related]
19. Non-apoptotic TRAIL function modulates NK cell activity during viral infection.
Cardoso Alves L; Berger MD; Koutsandreas T; Kirschke N; Lauer C; Spörri R; Chatziioannou A; Corazza N; Krebs P
EMBO Rep; 2020 Jan; 21(1):e48789. PubMed ID: 31742873
[TBL] [Abstract][Full Text] [Related]
20. UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells.
Samudio I; Rezvani K; Shaim H; Hofs E; Ngom M; Bu L; Liu G; Lee JT; Imren S; Lam V; Poon GF; Ghaedi M; Takei F; Humphries K; Jia W; Krystal G
Blood; 2016 May; 127(21):2575-86. PubMed ID: 26941401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
